Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...

Brian McKnight Jr. revealed his father could not say the words his brother Niko needed to hear before his untimely death.

After a contentious discussion, the vaccine advisory group pushed the vote to Friday to give members time to study the ...

From teasing toys to sultry lingerie, Lovehoney has everything you need to turn your cozy fall nights into a sultry adventure ...

HHT IMPACT enrolled 109 adult HHT patients with moderate-to-severe bleeding. The study implemented and validated the "During My Day Diary," which captured the frequency, duration, and intensity of ...

An autoinjector to administer Leqembi to patients with early-stage Alzheimer’s disease had high degrees of satisfaction for utility, feasibility and convenience for use at home, according to a poster.

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today presented new analysis from ...

Tanabe Pharma America, Inc. (TPA) today announced the presentation of exploratory preclinical findings into edaravone's activity in an ALS-relevant cell model. The data will be shared during the Motor ...

Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant ...

Atavistik Bio to present the discovery and characterization of novel allosteric JAK2 V617F selective inhibitors that suppress mutant-dependent ...

When weird fungal epidemics crop up in far-flung places, scientists work together to unravel how the microscopic murderers ...